KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Medtronic (MDT) Current Deferred Revenue (2025 - 2026)

Medtronic's Current Deferred Revenue history spans 2 years, with the latest figure at $283.0 million for Q1 2026.

On a quarterly basis, Current Deferred Revenue changed N/A to $283.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $283.0 million, a N/A change, with the full-year FY2025 number at $391.0 million, changed N/A from a year prior.
Current Deferred Revenue hit $283.0 million in Q1 2026 for Medtronic, down from $318.0 million in the prior quarter.
Over the last five years, Current Deferred Revenue for MDT hit a ceiling of $391.0 million in Q2 2025 and a floor of $283.0 million in Q1 2026.